Circulation research
-
Circulation research · Jan 2017
Randomized Controlled Trial Multicenter StudyPreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMI.
Despite direct immediate intervention and therapy, ST-segment-elevation myocardial infarction (STEMI) victims remain at risk for infarct expansion, heart failure, reinfarction, repeat revascularization, and death. ⋯ URL: http://www.clinicaltrials.gov. Unique identifier: NCT01495364.